Viewing StudyNCT05996263



Ignite Creation Date: 2024-05-06 @ 7:23 PM
Last Modification Date: 2024-10-26 @ 3:06 PM
Study NCT ID: NCT05996263
Status: RECRUITING
Last Update Posted: 2023-08-18
First Post: 2023-08-01

Brief Title: Prognostic Value of Combined Approach Based on KEAP1NFE2L2 Mutations and Pre-therapeutic FDG-PETCT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 50 Treated With Pembrolizumab PEMBROMIC
Sponsor: University Hospital Brest
Organization: University Hospital Brest

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-08-01
Start Date Type: ACTUAL
Primary Completion Date: 2023-08-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-08-31
Completion Date Type: ESTIMATED
First Submit Date: 2023-08-01
First Submit QC Date: August 16 2023
Study First Post Date: 2023-08-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-08
Last Update Post Date: 2023-08-18
Last Update Post Date Type: ACTUAL